Shares of Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) reached a new 52-week high on Monday . The stock traded as high as $67.42 and last traded at $66.34, with a volume of 19697 shares trading hands. The stock had previously closed at $64.71. Analyst Upgrades and Downgrades Several equities research analysts recently weighed […]
Disc Medicine (NASDAQ:IRON) Stock Rating Reaffirmed by Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Rock Springs Capital Management LP grew its position in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 16.0% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 363,468 shares of the company’s stock after purchasing an additional 50,000 shares during […]
/PRNewswire/ Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery and development of novel treatments for patients suffering.
/PRNewswire/ Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery and development of novel treatments for patients suffering.